Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 2-methoxy-4-(methylsulfonyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

114086-41-8

Post Buying Request

114086-41-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114086-41-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 114086-41-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,0,8 and 6 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 114086-41:
(8*1)+(7*1)+(6*4)+(5*0)+(4*8)+(3*6)+(2*4)+(1*1)=98
98 % 10 = 8
So 114086-41-8 is a valid CAS Registry Number.

114086-41-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxy-4-methylsulfonylbenzoic acid

1.2 Other means of identification

Product number -
Other names 4-Methansulfonyl-2-methoxy-benzoesaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114086-41-8 SDS

114086-41-8Relevant academic research and scientific papers

MODULATORS OF DOPAMINE NEUROTRANSMISSION

-

Page/Page column 38-39, (2009/12/05)

The present invention relates to novel1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically asdopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.

1,4-Benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate

Henderson, Elisa A.,Alber, Dagmar G.,Baxter, Robert C.,Bithell, Sian K.,Budworth, Joanna,Carter, Malcolm C.,Chubb, Ann,Cockerill, G. Stuart,Dowdell, Verity C. L.,Fraser, Ian J.,Harris, Robert A.,Keegan, Sally J.,Kelsey, Richard D.,Lumley, James A.,Stables, Jeremy N.,Weerasekera, Natasha,Wilson, Lara J.,Powell, Kenneth L.

, p. 1685 - 1692 (2008/02/01)

Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as representing a serious threat to patient groups with poorly functioning or immature immune systems. Rac

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 114086-41-8